The health care mergers and acquisitions market continues to be a private equity draw, with investors making significant investments in standalone platforms and platform add-on transactions, write attorneys with Katten Muchin Rosenman. Also at the fore are strategic private equity investments in joint ventures with non-controlling strategic investors adding value to overall joint-venture platforms. This relatively new model is increasingly popular in an environment focused on value-based care initiatives and risk-based programs.
Over the past four years, the market has experienced an uptick in specialty platforms such as urology, dermatology, ophthalmology, gastroenterology and orthopedics. As these standalone specialties mature, secondary transactions for these established platforms are on the rise. At the same time, new single-specialty platforms and multi-specialty platforms are emerging. Amid a booming specialty market featuring physician/provider models, there is growing interest in opportunities and development of in-home patient care and tech-enabled care solutions. Read more.
